Skip routine tests, CCP soldiers become "white mice"?

Report by : Gan Yung Chyan

                  / KUCINTA SETIA

On 22 June 2020, CanSino Bio published the results of clinical trials in the international authoritative medical journal The Lancet, showing that the vaccine is safe and all vaccinated people have an immune response.

The announcement on 29 June stated that this vaccine has already started Phase I and Phase II clinical trials in mainland China. It has been approved by the CMC and used in the CCP army.

The announcement stated that the health bureau of the Logistics Support Department of the CMC has issued approval documents on June 25, stating that these vaccines are "specially needed drugs" for the military and are valid for one year. "Apple Daily" said that this means "the vaccine can skip the conventional phase 3 trial and directly for military personnel to vaccinate."

As everyone knows, the success of the vaccine is marked by three points: safety, effectiveness and accessibility. "Accessibility" means that people can safely and practically obtain appropriate, high-quality and culturally acceptable medicines at affordable prices, and can easily obtain information about the rational use of medicines.

Among the three signs, the first two are the most important. Mainland China Finance and Economics pointed out, "The clinical phase I and phase II trials are mainly to verify the safety of the vaccine, and the vaccine as a key factor to end the epidemic, its ultimate success is based on large-scale phase III clinical trials. "

The article quoted a virologist as saying that "Phase III clinical trials often require tens of thousands of people." But now the CCP may directly vaccinate CCP soldiers after the first and second clinical trials.

"The Lancet" pointed out in a report that the first 108 people had undergone clinical tests. 75%-83% of people with different doses of vaccinations had adverse reactions. The most common side effects are pain at the injection site in 54%, followed by fever in 46%, fatigue in 44%, headache in 39% and muscle pain in 17%.

What is the problem behind this? Is it because the epidemic in the military is too serious to wait for the Phase 3 clinical trial? If it is not that the epidemic situation in the army is too heavy, does it mean that the CCP regards the soldiers as mice and takes them for an experiment?

It is understood that the United States plans to launch large-scale clinical trials in July, and each vaccine will recruit 20-30 thousand volunteers. The vaccine developed by Oxford University in the UK also plans to recruit 10,000 subjects in the second phase of the trial.

However, the CCP has reported false and toxic vaccine incidents many times earlier, and people still suffer from pain. How many people who are already shuddering will still be willing to test the CCP? If no volunteers are found, the CCP’s Phase III trial of vaccine development will be at a standstill.

In order to get ahead of other countries, the Chinese Communist Party has only forced ordinary soldiers of the military to do trials, but military officials will not be injected for the time being. In this kind of thing, the CCP will not directly say that the soldiers will be used for the experiment. It will find an excuse to confuse people: to use it for the army, but in fact it is to treat the soldiers as mice.